The decision from the Swedish Tax Agency states that it does not allow deductions for research and development (FOU) in employer declarations where the Company has made deductions for employer contributions for employees who work with FOU.

Nectarine Health's management and board have discussed with lawyers and with the Tax Agency's handlers and believe that the decision is incorrect and will therefore request a review.

"The company believes that Nectarines Health's research and development work should fall under the rules that apply to FOU. We will send in a more detailed description of how we work with this," says Christer Trägårdh, chairman of the board at Brighter AB and Nectarine Health.

The company currently has no information on when the decision on the review request will be made.

For more information, please contact:

Investor Relations
IR@brighter.se

Certified Adviser
Brighter's Certified Adviser is Mangold Fondkommission AB
About Brighter
Brighter is a health-tech company from Sweden with a vision of a world where managing chronic diseases is no longer a struggle. We believe a data-centric approach is key to providing smarter care for chronic conditions. Our daily-care solutions are designed with a vision to facilitate the flow of real-life treatment data between chronic-disease patients, their loved ones and their care providers - aiming to improve quality of life, easing the burden on healthcare systems, and opening new opportunities for data-driven research. Brighter's quality management system is ISO13485 certified. In 2019 the Company won the Swecare Rising Stars Award. The Company's shares are listed on Nasdaq First North Growth Market/BRIG. For more information, please visit our website at www.brighter.se.

This information is information that Brighter AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, on 2022-09-14 at 19:45